Literature DB >> 19765323

Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoni.

Y-S Liang1, W Wang, J-R Dai, H-J Li, Y-H Tao, J-F Zhang, W Li, Y-C Zhu, G C Coles, M J Doenhoff.   

Abstract

Praziquantel (PZQ) is now widely used for the treatment of human schistosomiasis. However, in recent years, there has been a growing concern about the resistance of Schistosoma to PZQ. The mechanisms of PZQ action against Schistosoma and resistance of Schistosoma to PZQ are poorly understood. Here, we report differential susceptibilities to PZQ between male and female cercariae in the PZQ-susceptible and PZQ-resistant isolates of Schistosoma mansoni, using tail loss as a measurement of PZQ action. The miracidia were collected by hatching eggs collected from faeces of infected mice. Single-sex cercaria lines were made by infecting a single Biomphalaria glabrata snail with a single miracidium. The sex of each single-sex cercaria line was identified by a direct W1-specific polymerase chain reaction (PCR) technique. Single-sex cercariae of two isolates were exposed to four different concentrations of PZQ, respectively. The tail shedding of cercariae was observed under a dissecting microscope for five time points up to 100 min after adding PZQ. The results showed that male cercariae have higher tail-shedding rates than that of female cercariae when PZQ-susceptible isolates of S. mansoni are exposed to the same concentration of PZQ. But this phenomenon was not observed in the PZQ-resistant isolates. This sexual differential resistance phenomenon of S. mansoni suggests that resistance to PZQ is induced by decreasing the PZQ susceptibility of male worms. The experiment described here may also be useful for developing tests to detect PZQ resistance in the field.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765323     DOI: 10.1017/S0022149X0999054X

Source DB:  PubMed          Journal:  J Helminthol        ISSN: 0022-149X            Impact factor:   2.170


  11 in total

Review 1.  New insight into praziquantel against various developmental stages of schistosomes.

Authors:  Wei Wu; Wei Wang; Yi-Xin Huang
Journal:  Parasitol Res       Date:  2011-10-08       Impact factor: 2.289

Review 2.  Susceptibility or resistance of praziquantel in human schistosomiasis: a review.

Authors:  Wei Wang; Li Wang; You-Sheng Liang
Journal:  Parasitol Res       Date:  2012-10-07       Impact factor: 2.289

3.  In vitro praziquantel test capable of detecting reduced in vivo efficacy in Schistosoma mansoni human infections.

Authors:  Poppy H L Lamberton; Sarah C Hogan; Narcis B Kabatereine; Alan Fenwick; Joanne P Webster
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

4.  Resolution of praziquantel.

Authors:  Michael Woelfle; Jean-Paul Seerden; Jesse de Gooijer; Kees Pouwer; Piero Olliaro; Matthew H Todd
Journal:  PLoS Negl Trop Dis       Date:  2011-09-20

5.  ULTRASTRUCTURAL CHANGES IN Schistosoma mansoni MALE WORMS AFTER in vitro INCUBATION WITH THE ESSENTIAL OIL OF Mentha x villosa Huds.

Authors:  Thiago José Matos-Rocha; Marília Gabriela dos Santos Cavalcanti; Dyana Leal Veras; Ana Paula Sampaio Feitosa; Gabriel Gazzoni Araújo Gonçalves; Nairomberg Cavalcanti Portela-Junior; Ana Silvia Suassuna Carneiro Lúcio; Anekécia Lauro da Silva; Rafael José Ribeiro Padilha; Márcia Ortiz Mayo Marques; José Maria Barbosa-Filho; Luiz Carlos Alves; Fábio André Brayner
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-02-23       Impact factor: 1.846

6.  Pharmacological inhibition of lysine-specific demethylase 1 (LSD1) induces global transcriptional deregulation and ultrastructural alterations that impair viability in Schistosoma mansoni.

Authors:  Vitor Coutinho Carneiro; Isabel Caetano de Abreu da Silva; Murilo Sena Amaral; Adriana S A Pereira; Gilbert Oliveira Silveira; David da Silva Pires; Sergio Verjovski-Almeida; Frank J Dekker; Dante Rotili; Antonello Mai; Eduardo José Lopes-Torres; Dina Robaa; Wolfgang Sippl; Raymond J Pierce; M Teresa Borrello; A Ganesan; Julien Lancelot; Silvana Thiengo; Monica Ammon Fernandez; Amanda Roberta Revoredo Vicentino; Marina Moraes Mourão; Fernanda Sales Coelho; Marcelo Rosado Fantappié
Journal:  PLoS Negl Trop Dis       Date:  2020-07-01

7.  The Role of Efflux Pumps in Schistosoma mansoni Praziquantel Resistant Phenotype.

Authors:  António Pinto-Almeida; Tiago Mendes; Ana Armada; Silvana Belo; Emanuel Carrilho; Miguel Viveiros; Ana Afonso
Journal:  PLoS One       Date:  2015-10-07       Impact factor: 3.240

Review 8.  Praziquantel treatment in trematode and cestode infections: an update.

Authors:  Jong-Yil Chai
Journal:  Infect Chemother       Date:  2013-03-29

9.  The cytotoxicity study of praziquantel enantiomers.

Authors:  Qian Sun; Ruifeng Mao; Dongling Wang; Changyan Hu; Yang Zheng; Dequn Sun
Journal:  Drug Des Devel Ther       Date:  2016-06-24       Impact factor: 4.162

10.  Inhibition of histone methyltransferase EZH2 in Schistosoma mansoni in vitro by GSK343 reduces egg laying and decreases the expression of genes implicated in DNA replication and noncoding RNA metabolism.

Authors:  Adriana S A Pereira; Murilo S Amaral; Elton J R Vasconcelos; David S Pires; Huma Asif; Lucas F daSilva; David A Morales-Vicente; Vitor C Carneiro; Claudia B Angeli; Giuseppe Palmisano; Marcelo R Fantappie; Raymond J Pierce; João C Setubal; Sergio Verjovski-Almeida
Journal:  PLoS Negl Trop Dis       Date:  2018-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.